AbbVie’s $55-billion bid for UK drug maker Shire was approved, providing yet another footnote in the history of corporate inversion on the part of US companies mainly looking to avoid corporate taxes. The combined firm will move to UK, saving upwards of $8 billion in US corporate taxes by some estimates. While such a move […]

We’ve always found the subject of valuation for technology companies a curious topic, one that we could probably bore too many people with during cocktail hour conversations. Last fall, we wrote about the topic of valuation in the Spend Matters PRO brief Procurement Vendor Valuation, M&A, and IPOs: Recent Deals and 2014 Forecast, touching on […]